| Literature DB >> 35011759 |
Christophe Beyls1,2, Yohann Bohbot3, Matthieu Caboche1, Pierre Huette1, Guillaume Haye1, Hervé Dupont1, Yazine Mahjoub1, Abou-Arab Osama1.
Abstract
(1) Background: Right ventricular (RV) strain parameters derived from the analysis of the tricuspid annular displacement (TAD) are emergent two-dimensional speckle tracking echocardiography (2D-STE) parameter used for the quantitative assessment of RV systolic function. Few data are available regarding 2D-STE parameters and their dependency on RV preload. Our aim was to evaluate the effect of an acute change in RV preload on 2D-STE parameters in healthy volunteers. (2)Entities:
Keywords: fluid challenge; preload; right ventricle; speckle tracking; strain
Year: 2021 PMID: 35011759 PMCID: PMC8745134 DOI: 10.3390/jcm11010019
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flow chart of the study population.
Figure 2RV 2D-STE parameters. (A) Right ventricular four-chamber strain (RV4CLS), including the ventricular septum. (B) Right ventricular free wall longitudinal strain (RVFWLS) in focused right ventricular view. In focused right ventricular view, septal segments are not compatible with the septal segments from a standard LV segmentation, and results can therefore not be used interchangeably. (C) In RV-focused view, user-defined anatomic landmarks lateral point (blue circle) and septal point (orange circle) were placed at the bottom of the RV free wall and the bottom of the interventricular septum, and another point was placed at the apex (yellow circle). TAD lateral, TAD septal, and RV-LSF (%) value were displayed.
Haemodynamic parameters before and after fluid challenge.
| Overall Population ( | Baseline | After FC | |
|---|---|---|---|
| Age (years) | 26 (24–28) | - | - |
| BMI (Kg/cm2) | 22 (20–24) | - | - |
| Male, | 28 (87) | - | - |
| Haemodynamic parameters | |||
| HR (bpm) | 64 (58–71) | 60 (54–69) | 0.03 |
| SAP (mmHg) | 119 (115–128) | 116 (110–121) | 0.02 |
| MAP (mmHg) | 84 (76–90) | 81 (75–89) | 0.18 |
| DAP (mmHg) | 68 (64–77) | 70 (62–75) | 0.71 |
Continuous variables are expressed as median (interquartile range) and categorical variables as number (percentage). BMI, body mass index; DAP, diastolic blood pressure; FC, fluid challenge; MAP, mean blood pressure; HR, heart rate; SAP, systolic blood pressure.
Echocardiographic parameters before and after fluid challenge.
| Overall Population ( | Baseline | After FC | |
|---|---|---|---|
| LV systolic parameters | |||
| LVEF (%) | 61 (58–68) | 60 (55–66) | 0.18 |
| LV end diastolic volume (mL) | 113 (94–118) | 111 (94–121) | 0.29 |
| LV end systolic volume (mL) | 43 (34–49) | 45 (34–52) | 0.21 |
| Stroke volume (mL s−1) | 72 (61–79) | 75 (65–80) | 0.07 |
| CO (L min−1) | 4.6 (3.9–5.2) | 4.2 (3.7–5.3) | 0.52 |
| LV diastolic functional parameters | |||
| E wave (cm s−1) | 84 (74–94) | 88 (78–95) | 0.09 |
| A wave (cm s−1) | 42 (38–54) | 47 (40–59) | 0.16 |
| E/A ratio | 1.8 (1.6–2.2) | 1.8 (1.7–2.1) | 0.93 |
| Lateral E/e’ | 4.2 (3.8–5) | 4.5 (4.1–5.4) | 0.22 |
| Deceleration time (ms) | 204 (168–266) | 202 (68–269) | 0.7 |
| LA volume index (mL m−2) | 18 (20–23) | 21 (19–23) | 0.92 |
| RV Parameters | |||
| RVOT PSAX distal dimension (mm) | 27 (24–32) | 30 (27–33) | 0.46 |
| RVOT PLAX proximal dimension (mm) | 31 (26–34) | 31 (27–34) | 0.11 |
| RV basal dimension (mm) | 40 (36–44) | 39 (37–42) | 0.78 |
| RV mid-cavity dimension (mm) | 3.6 (3.5–4) | 3.8 (3.7–4) | 0.01 |
| RV longitudinal dimension (mm) | 8.3 (8–8.5) | 8.3 (7.9–8.5) | 0.82 |
| RV EDA (mL) | 21 (16–23) | 21 (18–34) | 0.16 |
| RV ESA (mL) | 11 (9–15) | 12 (10–15) | 0.62 |
| RA volume indexed to BSA (mL/m2) | 23 (19–27) | 24 (22–29) | 0.63 |
| IVC collapsibility index (%) | 35.5 (28–55) | 24 (22–30) | 0.001 |
| RV Systolic Function Parameters | |||
| TAPSE (mm) | 23 (20–27) | 25 (21–28) | 0.06 |
| RV- S’ (cm/s−1) | 15 (11–16) | 14 (13–16) | 0.9 |
| RV FAC (%) | 42 (33–48) | 42 (37–46) | 0.7 |
| IVA (m s−2) | 3.2 (2.5–3.7) | 3 (2.5–3.5) | 0.29 |
| 2D STE RV Strain | |||
| RVFWLS (%) | −24.3 (22.5–28.9) | −24.9 (23.4–29) | 0.34 |
| RV4CLS (%) | −22.6 (20.7–25.4) | −23.5 (22.0–26.1) | 0.05 |
| TAD parameters | |||
|
TADlat (mm) TADsep (mm) RV-LSF (%) | 22.7 (20.5–25) | 24.6 (21.3–26.3) | 0.08 |
| 15.2 (13.7–17.3) | 16.1 (13.1–19.5) | 0.44 | |
| 24.2 (22.2–27) | 25 (21–29.4) | 0.3 |
Continuous variables are expressed as median (interquartile range) and categorical variables as number (percentage). 2D-STE, bi-dimensional speckle tracking echocardiography; CO, cardiac output; IVC, inferior vena cava; LA, left atrial; LV, left ventricular; LVEF, left ventricular ejection fraction; PSAX, para-sternal short axis; PLAX, para-sternal longue axis; RA, right atrial; RV, right ventricle; RV EDA, Right ventricle end-diastolic area; RV ESA, right ventricle end-systolic area; RV-FAC, right ventricle fractional area change; RV4CLS, right ventricle four chamber longitudinal strain; RVFWLS, right ventricle free wall longitudinal strain; RV-LSF, right ventricle longitudinal shortening fraction; RVOT, right ventricular outflow tract; TAD, tricuspid annular displacement; TAPSE, tricuspid annular plane systolic excursion; VTI, velocity time integral.
Hemodynamic and echocardiographic parameters in the responder group before and after fluid challenge.
| Responder Group ( | Baseline | After FC | |
|---|---|---|---|
| Hemodynamic parameters | |||
| HR (bpm) | 64 (57–74) | 61 (56–67) | 0.09 |
| SAP (mmHg) | 119 (113–125) | 112 (107–117) | 0.25 |
| MAP (mmHg) | 79 (75–87) | 77 (73–84) | 0.41 |
| DAP (mmHg) | 65 (62–68) | 67 (60–72) | 0.93 |
| LV systolic parameters | |||
| LVEF (%) | 59 (55–68) | 59 (57–64) | 0.65 |
| LV end diastolic volume (mL) | 112 (88–116) | 113 (94–125) | 0.24 |
| LV end systolic volume (mL) | 43 (32–51) | 45 (34–52) | 0.59 |
| Aortic VTI (cm/s−1) | 18 (16–20) | 22 (19–25) | 0.001 |
| Stroke Volume (mL) | 62 (54–70) | 75 (64–80) | 0.001 |
| RV Function | |||
| TAPSE (mm) | 20 (20–23.5) | 24 (21–29) | 0.02 |
| RV- S’ (cm s−1) | 15 (11–16) | 14 (13–16) | 0.44 |
| RV FAC (%) | 42 (36–48) | 43 (37–46) | 0.31 |
| IVA (m s−2) | 3.1 (2.5–3.5) | 3.0 (2.6–3.6) | 0.44 |
| RV Strain | |||
| RVFWSL (%) | −23.5 (22.3–27.3) | −25.0 (24.0–29.6) | 0.03 |
| RV4CSL (%) | −22.8 (20.4–30.7) | −23.7 (21.2–27.0) | 0.02 |
| TMAD | |||
|
TADlat (mm) TADsep (mm) RV-LSF (%) | 22 (20–24) | 24 (18–26) | 0.27 |
| 15 (14–18) | 16 (13–20) | 0.43 | |
| 24 (22–27) | 25 (20–30) | 0.63 |
2D-STE, bi dimensional speckle tracking echocardiography; CO, cardiac output; LA, left atrial; LV, left ventricular; LVEF, left ventricular ejection fraction; PSAX, para-sternal short axis; PLAX, para-sternal longue axis; RA, right atrial; RV, right ventricle; RV EDA, right ventricle end-diastolic area; RV ESA, right ventricle end-systolic area; RV4CLS, right ventricle four chamber longitudinal strain; RVFWLS, right ventricle free wall longitudinal strain; RV-FAC, right ventricle fractional area change; RV-LSF, right ventricle longitudinal shortening fraction; RVOT, right ventricular outflow tract; TAD, tricuspid annular displacement; TAPSE, tricuspid annular plane systolic excursion; VTI, velocity time integral.
Figure 3Stroke volume (A), RV4CLS (B), RVFWLS (C), and TAPSE (D) at baseline and after FC in the responder group (blue line).